NHC Stock Cash Flow Statements

National HealthCare Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

National HealthCare Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31

cash flows from operating activities:
net income	24,113,000	32,290,000	6,029,000	42,700,000	27,106,000	26,251,000	27,965,000	10,121,000	15,917,000	11,285,000	5,574,000	-3,107,000	2,161,000	15,349,000	15,995,000	-3,546,000			27,416,000	12,868,000			13,687,000	19,376,000	13,682,000	21,231,000	18,136,000	21,087,000	22,375,000	-2,899,000	21,296,000	12,633,000	11,110,000	11,866,000	13,699,000	12,567,000	12,358,000	13,242,000	12,829,000	12,511,000	13,229,000	19,877,000	14,342,000	13,805,000	17,233,000	13,614,000	12,676,000	17,211,000	13,611,000	18,724,000	15,083,000	11,850,000	10,407,000	12,344,000	11,367,000	9,184,000	13,773,000	9,486,000	8,172,000	13,126,000	11,892,000	7,040,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	11,015,000	10,978,000	11,442,000	10,619,000	9,338,000	10,586,000	11,768,000	10,135,000	10,083,000	10,048,000	10,478,000	10,253,000	10,001,000	9,757,000	10,151,000	10,229,000	10,131,000	10,161,000	10,487,000	10,548,000	10,545,000	10,438,000	10,904,000	10,663,000	10,335,000	10,517,000	10,718,000	10,437,000	10,397,000	10,342,000	11,043,000
equity in earnings of unconsolidated investments			0	62,000	-584,000	-67,000	-74,000	-185,000	-221,000	-1,535,000	21,000	-34,000	-10,000	-454,000	209,000	-14,000	-2,395,000	-2,911,000	-3,894,000	-3,019,000	-2,618,000	-2,811,000									-1,024,000																													-1,734,000	-1,422,000	-1,175,000
distributions from unconsolidated investments			0	0			0	1,000			0	0			0	0	417,000	5,897,000	0	3,149,000	4,552,000	2,349,000	18,000	1,275,000	2,578,000	31,000	1,411,000	89,000	1,487,000	2,254,000	81,000																													311,000	1,781,000	118,000
unrealized gains on marketable equity securities	5,061,000	-10,982,000		-32,767,000	-9,124,000	-14,399,000				-1,386,000				-3,126,000									3,866,000
realized gains on sale of marketable securities
gain on sale of unconsolidated company			0	0	0	-1,024,000
gain on sale of property and equipment
deferred income taxes	-2,762,000	1,356,000	2,382,000	9,518,000	3,557,000	2,484,000	6,827,000	-2,256,000	866,000	331,000	1,018,000	1,011,000	1,366,000	2,600,000	-866,000	-5,288,000	-1,736,000	1,596,000	-188,000	1,124,000	3,479,000	-15,008,000	-2,135,000	4,893,000	-309,000	1,603,000	-349,000	3,443,000	2,830,000	-5,206,000	-5,595,000																													4,063,000	-6,000	-12,804,000
stock–based compensation	1,233,000	1,027,000	1,098,000	1,093,000	1,176,000	793,000	663,000	708,000	772,000	639,000	632,000	639,000	629,000	712,000	715,000	726,000	683,000	496,000	646,000	518,000	823,000	466,000	430,000	340,000	684,000	424,000	240,000	361,000	749,000	428,000	415,000																															305,000
changes in operating assets and liabilities:
accounts receivable	-320,000	-6,416,000	-6,543,000	-19,056,000	16,277,000	-17,119,000	-5,942,000	-1,343,000	1,874,000	-3,148,000	-983,000	1,412,000	1,333,000	-5,624,000	2,895,000	-1,207,000	7,024,000	-4,622,000	-5,075,000	1,254,000	14,562,000	-6,212,000	-935,000	5,408,000	3,171,000	-3,345,000	-10,011,000	-3,924,000	2,776,000	1,761,000	-6,153,000																													-5,847,000
inventories	187,000	960,000	-1,197,000	-156,000	131,000	623,000	-13,000	-378,000	-49,000	142,000	210,000	65,000	1,223,000	-4,000	114,000	-757,000	178,000	664,000	-1,593,000	12,000	704,000	-372,000	333,000	-457,000	-364,000	517,000	120,000	-284,000	-40,000	-113,000	-40,000
prepaid expenses and other assets	-468,000	445,000	-2,526,000	4,320,000	1,336,000	3,153,000	-3,113,000	2,457,000	-1,970,000	1,957,000	373,000	-4,548,000	-2,551,000	-4,385,000	-1,613,000	593,000	-1,677,000	-601,000	1,735,000	755,000	3,752,000	-1,515,000	-456,000	759,000	418,000	-1,008,000	-407,000	215,000	-920,000	-631,000	146,000																													183,000	-59,000	-1,194,000
operating lease obligations	176,000	175,000	80,000	73,000	65,000	55,000	-308,000	-313,000	-307,000	-316,000
trade accounts payable	-367,000	-3,847,000	2,769,000	942,000	1,085,000	1,503,000	2,723,000	1,951,000	1,580,000	-4,018,000	-2,485,000	-6,697,000	298,000	3,354,000	-10,412,000	10,654,000	2,674,000	-4,999,000	1,222,000	1,448,000	167,000	-1,408,000	210,000	2,956,000	-3,581,000	-441,000	148,000	3,131,000	-549,000	737,000	1,242,000																															-783,000
accrued payroll	15,384,000	3,541,000	2,962,000	3,862,000	18,081,000	-19,954,000	14,391,000	2,390,000	10,619,000	-15,800,000	-4,832,000	-8,319,000	11,784,000	-32,821,000	20,772,000	-7,338,000	25,635,000	-21,777,000	25,493,000	-520,000	12,318,000	-21,343,000	10,329,000	2,806,000	10,803,000	-21,730,000	9,131,000	2,799,000	11,205,000	-22,619,000	11,516,000																													10,228,000	3,195,000	-5,522,000
amounts due to third party payors	1,263,000	-1,454,000	-3,464,000	597,000	-1,770,000	1,619,000	2,781,000	-71,000	-1,020,000	48,000	1,135,000	-2,523,000	700,000	-276,000	549,000	115,000	865,000	-880,000	812,000	-2,182,000	2,217,000	353,000	-803,000	-888,000	506,000	185,000	-1,488,000	378,000	63,000	-234,000	-3,260,000																													1,875,000	-1,296,000	-216,000
accrued risk reserves	785,000	4,581,000	-6,588,000	950,000	1,017,000	4,978,000	-4,866,000	1,905,000	594,000	3,157,000	-1,241,000	1,047,000	1,250,000	3,365,000	-5,776,000	1,974,000	368,000	1,945,000	-6,523,000	1,117,000	4,237,000	4,623,000	-1,701,000	1,014,000	-1,271,000	2,498,000	150,000	1,130,000	-1,433,000	2,971,000	-1,305,000
other current liabilities	11,210,000	5,919,000	-15,783,000	11,134,000	-11,000	1,311,000	-8,659,000	4,249,000	4,379,000	5,407,000	-6,458,000	3,723,000	-1,410,000	1,701,000	-3,490,000	3,910,000	-6,131,000	4,331,000	-2,086,000	-3,995,000	8,614,000	3,365,000	-7,565,000	4,264,000	-4,077,000	8,158,000	-2,312,000	1,648,000	496,000	-1,882,000	-4,099,000
other noncurrent liabilities	154,000	923,000	-2,442,000	297,000	-9,858,000	1,530,000	-243,000	-201,000	316,000	6,554,000	4,679,000	-2,171,000	-512,000	1,386,000	-9,932,000	-2,833,000	-695,000	1,598,000	-4,299,000	3,606,000	9,307,000	-1,468,000	2,293,000	-1,630,000	89,000	102,000	501,000	-1,632,000	203,000	337,000	253,000																													-12,000	-2,252,000	11,574,000
net cash from operating activities	62,819,000	39,255,000	12,789,000	34,207,000	50,661,000	9,646,000									15,523,000	6,749,000	27,533,000	12,589,000	19,359,000	29,173,000	146,973,000	7,754,000	25,219,000	35,712,000	27,571,000	11,601,000	21,369,000	27,693,000	36,067,000	13,306,000	23,471,000																													13,270,000	14,256,000	7,258,000
capex	-10,204,000	-6,137,000	-8,156,000	-5,656,000	-7,833,000	-5,955,000									-13,625,000	-12,631,000	-8,816,000	-4,327,000	-4,156,000	-5,200,000	0	-6,628,000	-6,730,000	-5,681,000	-8,115,000	-5,874,000	-7,064,000	-7,252,000	-8,356,000	-7,100,000	-8,019,000																													-3,399,000	-3,608,000	-4,814,000
free cash flows	52,615,000	33,118,000	4,633,000	28,551,000	42,828,000	3,691,000									1,898,000	-5,882,000	18,717,000	8,262,000	15,203,000	23,973,000	146,973,000	1,126,000	18,489,000	30,031,000	19,456,000	5,727,000	14,305,000	20,441,000	27,711,000	6,206,000	15,452,000																													9,871,000	10,648,000	2,444,000
cash flows from investing activities:
purchases of property and equipment	-10,204,000	-6,137,000	-8,156,000	-5,656,000	-7,833,000	-5,955,000	-8,601,000	-6,511,000	-6,149,000	-6,640,000	-5,637,000	-7,530,000	-8,071,000	-8,962,000	-13,625,000	-12,631,000	-8,816,000	-4,327,000	-4,156,000	-5,200,000
proceeds from the sale of unconsolidated company				0
collections of (investments in) notes receivable
investments in unconsolidated companies	-786,000	-2,419,000	-5,928,000	-3,514,000	-3,368,000	-1,488,000									0				0	-120,000	-60,000	-125,000			-231,000	-125,000					-70,000
purchases of marketable securities	-36,214,000	-11,062,000	-10,321,000	-5,838,000	-10,195,000	-8,703,000	-7,738,000	-7,357,000	-4,125,000	-10,281,000	-5,076,000	-3,820,000	-10,769,000	-14,128,000			-35,617,000	-7,866,000
proceeds from sale of marketable securities	31,167,000	12,288,000		5,114,000	23,047,000	11,615,000		8,527,000	12,559,000	15,492,000		7,300,000	13,868,000	16,946,000			38,853,000	6,086,000
net cash from investing activities	-15,579,000	-7,323,000	-11,645,000	-224,058,000	1,425,000	-2,415,000	-10,186,000	-5,135,000	-820,000	-1,427,000	2,832,000	-647,000	-2,243,000	-5,920,000	-13,052,000	-20,842,000	-26,143,000	-5,852,000	-48,605,000	3,294,000	-2,342,000	-16,225,000	-4,442,000	1,547,000	-8,423,000	-2,947,000	-6,572,000	-10,288,000	-10,974,000	-5,828,000	-10,750,000																													-2,402,000	-1,267,000	1,751,000
cash flows from financing activities:
repayments under credit facility	-24,000,000	-3,000,000	-10,000,000																	0
principal payments under finance lease obligations			0	0	0	-860,000	-1,274,000	-1,256,000	-1,237,000	-1,218,000	-1,200,000	-1,183,000	-1,165,000	-1,147,000	-1,131,000	-1,114,000	-1,097,000	-1,081,000	-1,065,000	-1,049,000	-1,033,000	-1,019,000	-1,003,000	-988,000	-973,000	-959,000
dividends paid to common stockholders	-9,434,000	-9,420,000	-9,419,000	-9,408,000	-9,086,000	-9,051,000	-9,040,000	-9,039,000	-8,733,000	-8,748,000	-8,774,000	-8,828,000	-8,509,000	-8,493,000	-8,020,000	-8,020,000	-8,002,000	-7,988,000	-7,986,000	-7,987,000	-7,980,000	-7,968,000	-7,968,000	-7,965,000	-7,652,000	-7,623,000	-7,613,000	-7,612,000	-7,305,000	-7,297,000	-7,294,000
issuance of common shares			797,000	2,232,000			53,000	254,000			833,000	161,000			1,036,000	0	2,078,000	327,000	681,000	126,000	549,000	400,000	963,000	0	804,000	579,000	1,538,000	0	260,000	1,067,000	897,000																													5,000	177,000	317,000
repurchase of common shares	-4,662,000	-1,722,000	0	-2,100,000	-1,502,000	-9,900,000	0	0	0	-2,482,000	-2,996,000	-6,761,000	0	-146,000	-558,000	0	0	-278,000	0	0	0	-53,000	0	0	0	-872,000	0	0	0	-867,000
entrance fee deposits	-127,000	171,000																																																										-230,000	392,000	-217,000
net cash from financing activities	-33,039,000	-12,693,000			-7,613,000	-12,067,000	-9,834,000	-9,820,000	-10,272,000	-12,619,000	-12,101,000	-16,744,000	-8,347,000	-10,450,000	-9,495,000	-9,727,000			-8,370,000	-7,128,000	-58,032,000	31,641,000	-27,849,000	-35,083,000	-7,941,000	-8,875,000	-27,610,000	-18,543,000	-22,962,000	-8,159,000	-27,040,000																													-3,223,000	-2,533,000	-2,441,000
net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents																			-37,616,000	25,339,000	86,599,000	23,170,000	-7,072,000	2,176,000			-12,813,000	-1,138,000	2,131,000	-681,000	-14,319,000	32,220,000
cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	0	96,922,000	0	0	0	125,968,000	0	0	0	74,865,000	0	0	0	119,743,000	0	0	0	158,502,000	0	0	0	61,010,000	0	0	0	54,920,000	0	0	0	67,421,000	0	31,589,000
cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	14,201,000	116,161,000	-18,152,000	-50,531,000	44,473,000	121,132,000	5,713,000	17,350,000	28,229,000	74,676,000	2,665,000	-19,368,000	15,652,000	75,916,000	-7,024,000	-23,820,000	-5,504,000	156,091,000	-37,616,000	25,339,000	86,599,000	84,180,000	-7,072,000	2,176,000	11,207,000	54,699,000	-12,813,000	-1,138,000	2,131,000	66,740,000	-14,319,000	63,809,000
balance sheet classifications:
cash and cash equivalents	20,606,000	90,386,000	-8,686,000	-51,407,000	42,232,000	93,982,000	6,768,000	21,816,000	32,348,000	46,144,000	14,152,000	-31,283,000	18,805,000	56,993,000	-4,855,000	-22,230,000	585,000	134,107,000	-36,672,000	34,294,000	79,979,000	69,492,000	-8,927,000	29,515,000	-8,448,000	38,194,000	-12,352,000	-3,723,000	4,360,000	54,962,000	-10,672,000	47,096,000
restricted cash and cash equivalents	-6,405,000	25,775,000	-9,466,000	876,000	2,241,000	27,150,000	-1,055,000	-4,466,000	-4,119,000	28,532,000	-11,487,000	11,915,000	-3,153,000	18,923,000	-2,169,000	-1,590,000	-6,089,000	21,984,000	-944,000	-8,955,000	6,620,000	14,688,000	1,855,000	-27,339,000	19,655,000	16,505,000	-461,000	2,585,000	-2,229,000	11,778,000	-3,647,000	16,713,000
total cash, cash equivalents, restricted cash, and restricted cash equivalents	14,201,000	116,161,000	-18,152,000	-50,531,000	44,473,000	121,132,000	5,713,000	17,350,000	28,229,000	74,676,000	2,665,000	-19,368,000	15,652,000	75,916,000	-7,024,000	-23,820,000	-5,504,000	156,091,000	-37,616,000	25,339,000	86,599,000	84,180,000	-7,072,000	2,176,000	11,207,000	54,699,000	-12,813,000	-1,138,000	2,131,000	66,740,000	-14,319,000	63,809,000
gains on sale of marketable securities		-241,000
contract liabilities						7,667,000					-138,000	-448,000	-4,417,000	-10,019,000	-11,991,000	-13,108,000			0	261,000
proceeds from sale of unconsolidated company						2,100,000
collections of notes receivable		7,000				16,000				2,000	-302,000	3,728,000	229,000	224,000	220,000	215,000	8,150,000	255,000	911,000	433,000	763,000	376,000	369,000	350,000	307,000	353,000	373,000	380,000	369,000	431,000	312,000																															6,447,000
issuance of common stock		1,278,000				8,412,000
net increase/(decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents		19,239,000						17,350,000
unrealized (gains) losses on marketable equity securities																									54,000	-6,838,000
(gains) losses on sale of marketable securities
impairment (recovery) of assets
provider relief funds											-516,000	0	0	-8,927,000	9,443,000	-10,429,000	-13,081,000	7,442,000	-5,336,000	2,110,000
acquisition of white oak manor, net of cash acquired
acquisition of other businesses, net of cash acquired			0
proceeds from sale of assets
(investments in) collections of notes receivable
sale of marketable securities																																																												0
borrowings under credit facility			0																0	0	0	40,000,000
debt issuance costs
noncontrolling interest contributions			-274,000								0	0	0	250,000
net cash from / (used in) financing activities
realized (gains)/losses on sale of marketable securities				19,000
acquisition of white oak senior living, net of cash acquired
investments in notes receivable				135,000															0	0	-175,000	-250,000	0	-150,000	-5,000,000	-312,000
entrance fee refunds				207,000	148,000	-668,000		221,000	-308,000	-171,000		-133,000	207,000	-914,000				-128,000					61,000	-581,000				0	0	-159,000
net cash provided by/(used in) financing activities
acquisition of skilled nursing facility							0	0
(gains)/losses on sale of marketable securities						-344,000				492,000		392,000
net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents						-4,836,000				-189,000		-19,368,000	15,652,000	-43,827,000												-221,000
gain on acquisition of equity method investment																						-1,707,000		0			0
proceeds from the sale of property and equipment											0
acquisition of equity method investment																							0	0
unrealized (gains)/losses on marketable equity securities								3,093,000									6,489,000	-7,059,000		241,000	-20,053,000	60,392,000
realized losses on sale of marketable securities								42,000
recovery of notes receivable
net cash provided by/(used in) operating activities								32,305,000	39,321,000	13,857,000
investments in notes receivable
(investments in)/collections of notes receivable
unrealized losses on marketable equity securities											4,327,000
gains on acquisition of equity method investments
acquisition of equity method investments
principal payments under credit facility
net cash provided by/(used in) operating activities
acquisition of equity method investment, net of cash acquired																				0	0	-6,648,000					0
investments in unconsolidated companies and notes receivable
proceeds from sale of real estate
adjustments to reconcile net income to net cash (used in)/provided by operating activities:
gains on sale of marketable securities														-45,000
net cash (used in)/provided by operating activities														-27,457,000
unrealized losses (gains) on marketable equity securities
gains on acquisitions of equity method investments															0	0				0
gain on sale of skilled nursing facility
impairment of assets
federal income tax receivable
proceeds from the sale of skilled nursing facility
acquisitions of equity method investments
gains on sales of marketable securities
acquisitions of equity method investments, net of cash acquired																0
purchases of marketable securities
proceeds from sale of marketable securities
entrance fee (refunds) deposits																-593,000
net (decrease)/increase in cash, cash equivalents, restricted cash, and restricted cash equivalents																-23,820,000	-5,504,000	-2,411,000
gains on sale of marketable debt securities
net income/																		21,308,000				-26,816,000
net cash (used in)/provided by financing activities																		-9,148,000
gains on sale of restricted marketable debt securities																				-122,000	-11,000	-2,000	-10,000
income tax receivable																						2,560,000						-2,203,000	1,527,000	3,938,000
purchases of restricted marketable debt securities																				0			-1,284,000
proceeds from sale of restricted marketable debt securities																				8,181,000
noncontrolling interest contributions/																				1,963,000
entrance fee deposits/																				-181,000
deferred revenue																						1,870,000	-683,000	-561,000	-692,000	2,018,000	-838,000	-729,000	-635,000	2,030,000	-781,000
additions to property and equipment																						-6,628,000	-6,730,000	-5,681,000	-8,115,000	-5,874,000	-7,064,000	-7,252,000	-8,356,000	-7,100,000	-8,019,000
purchase of restricted marketable debt securities																						-6,360,000			-3,322,000	-3,565,000
sale of restricted marketable debt securities																						3,410,000			23,527,000	6,576,000
equity contributed by noncontrolling entities																						281,000
obligation to provide future services
principal payments under line of credit agreement
distributions attributable to noncontrolling interest																							98,000	-549,000
equity contributed by noncontrolling interest
equity in (earnings) losses of unconsolidated investments																								-2,747,000	-2,480,000	-2,321,000		-2,724,000	-2,002,000	6,586,000
(investments in)/distributions from unconsolidated investments
sales of restricted marketable debt securities
principal payments on debt																												-10,000,000
unrealized gains on marketable securities
principal payments under capital lease obligations																											-945,000	-931,000	-917,000	-903,000	-890,000
equity attributable to noncontrolling interest																															247,000
tax expense from exercise of stock options
change in deposits
distributions from/(investments in) unconsolidated companies
purchase of restricted marketable securities																												-3,405,000	-3,851,000	-2,694,000
sale of restricted marketable securities																												140,000	864,000	3,535,000
gains on sale of restricted marketable securities																													-14,000	-11,000
unrealized losses on marketable securities																														15,517,000
benefit from doubtful accounts
redemption of preferred shareholders
dividends paid to preferred stockholders
tax benefit from exercise of stock options																																																												0	133,000	62,000
benefit from doubtful accounts receivable																																																												49,000	429,000	388,000
changes in operating assets and liabilities, net of the effect of acquisitions:
purchases of restricted marketable securities
sales of restricted marketable securities
tax expense from stock–based compensation
net increase in cash and cash equivalents																																	-18,331,000	-11,640,000	10,975,000	-719,000	-6,711,000	8,444,000	1,159,000	-8,379,000	2,432,000	13,776,000	795,000	7,138,000	14,498,000	9,495,000	-1,294,000	15,827,000	3,827,000	5,026,000	6,305,000	-5,226,000	-11,233,000	10,583,000	3,918,000	11,585,000	19,966,000	12,503,000	14,909,000	7,645,000	10,456,000	6,568,000
cash and cash equivalents, beginning of period																																	0	0	38,208,000	0	0	69,767,000	0	0	81,705,000	0	0	66,701,000	0	0	61,008,000	0	0	28,478,000	0	0	39,022,000	0	0	49,033,000	0	0	2,379,000	0	0	50,678,000
cash and cash equivalents, end of period																																	-18,331,000	-11,640,000	49,183,000	-719,000	-6,711,000	78,211,000	1,159,000	-8,379,000	84,137,000	13,776,000	795,000	73,839,000	14,498,000	9,495,000	59,714,000	15,827,000	3,827,000	33,504,000	6,305,000	-5,226,000	27,789,000	10,583,000	3,918,000	60,618,000	19,966,000	12,503,000	17,288,000	7,645,000	10,456,000	57,246,000
supplemental disclosure of non-cash investing and financing activities:
buildings, personal property, and obligations recorded under capital lease agreements																																							0	0	39,032,000
adjustments to reconcile net income to net cash
depreciation																																																												3,881,000	3,771,000	3,792,000
amortization of intangibles and deferred charges																																																												10,000	11,000	10,000
gain on sale of land
amortization of deferred income																																																												368,000	-468,000	-354,000
deferred income																																																												-932,000	-870,000	2,669,000
decrease (increase) in restricted cash																																																												2,369,000
stock based compensation																																																												386,000
amortization of deferred lease credit
inventory																																																												173,000	-8,000	-91,000
accounts payable																																																												580,000
accrued interest																																																														205,000
other current liabilities and accrued reserves																																																												-3,563,000
additions to and acquisitions of property and equipment																																																												-3,399,000	-3,608,000	-4,814,000
collection of notes receivable																																																												686,000
purchase of marketable securities
increase in minority interests in consolidated subsidiaries																																																													1,000	-11,000
increase in bond reserve funds, mortgage replacement reserves
and other deposits																																																												-30,000
dividends paid to shareholders																																																												-2,633,000	-2,255,000	-2,248,000
payments on debt																																																												-569,000	-563,000	-554,000
increase in restricted cash																																																														-5,594,000
changes in assets and liabilities:
accounts (and other) receivables																																																														2,354,000
other current liabilities and accrued risk reserves																																																														6,871,000
increase in bond reserve funds and other deposits
supplemental information:
cash payments for interest																																																														71,000
cash payments for income taxes																																																														550,000
provided by operating activities:
write-off of notes receivable
realized gain on sale of marketable securities
stock compensation
tax refund receivable
disposals of property and equipment
collections of receivables from exercise of options
increase in bond reserve funds, mortgage
replacement reserves and other deposits
purchase of common shares
increase in bond reserve funds, mortgage replacement reserves and other deposits
increase in financing costs

We provide you with 20 years of cash flow statements for National HealthCare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of National HealthCare stock. Explore the full financial landscape of National HealthCare stock with our expertly curated income statements.

The information provided in this report about National HealthCare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.